Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is supplied as a pre-filled KwikPen — a self-contained device designed so that no separate syringe is needed. Attempts to draw tirzepatide from the pen into an insulin syringe are not supported by the licensed method of use, carry real safety risks, and are not recommended by the manufacturer or UK clinical guidance. Here is what the evidence and the official prescribing information say, and why the KwikPen design exists in the first place. As a prescription-only medicine, Mounjaro can only be obtained following a clinical assessment with a qualified prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC, reviewed and maintained on the electronic Medicines Compendium (eMC), specifies subcutaneous injection using the pre-filled KwikPen only. Each pen comes pre-loaded with four weekly doses of tirzepatide at a precise concentration. The pen's dial selects one dose at a time; the needle attaches to the pen tip; the medicine is delivered by pressing the injection button. That sequence is the entire licensed method. There is no step involving a separate syringe, and no clinical validation behind any alternative approach. The NHS medicines page for tirzepatide reinforces this: patients are directed to follow the instructions in their Patient Information Leaflet and not to adapt the delivery method. If you have questions about the injection technique, your prescriber or pharmacist is the right person to ask, not a forum thread. The full injection guidance for Mounjaro covers the authorised steps in plain language.
Insulin syringes are calibrated in insulin units (IU), a measurement system specific to insulin concentration. Tirzepatide is expressed in milligrams per dose, delivered via a fixed-volume mechanism inside the KwikPen. The two systems are not interchangeable, and there is no reliable conversion that a patient could apply safely at home. Even setting the unit mismatch aside, the KwikPen is not a multi-dose vial with a rubber septum. It is a pen-injector: attempting to extract solution by inserting a needle into any part of the pen risks introducing air into the cartridge, disturbing the remaining doses, or contaminating the solution. Any of those outcomes could affect the accuracy of subsequent doses. Clinical pharmacists flag this type of off-label delivery as a medication safety concern, not a minor technical variation. If you are wondering what size syringe is appropriate for Mounjaro, the short answer is that the KwikPen removes the need for one entirely, which helps avoid these errors before they happen.
The only additional consumable the KwikPen requires is a compatible pen needle, attached fresh for each injection and disposed of safely in a sharps container afterwards. The pen needle gauge and length that suits you is a conversation for your prescriber, since skin thickness, injection site and comfort all play a role. Injection sites are the abdomen, outer thigh or upper arm; rotating between them reduces the chance of localised skin reactions. Storage is straightforward: keep the pen in the fridge (many people find the pen door easiest, same place, every time) until the day before injection, then allow it to come to room temperature. The exact room-temperature window is specified in the SmPC and Patient Information Leaflet; always check those documents rather than relying on general summaries. For a practical overview of needle options and sizes, the guide to Mounjaro syringes and needles covers what is compatible and why.
The insulin-syringe question usually surfaces in one of two situations: someone has seen a compounded or unlicensed tirzepatide product supplied in a vial (common outside the UK, and sometimes offered by unregulated sellers here), or someone is trying to manage a dose differently than their prescriber has set. Both situations warrant a direct conversation with a clinician rather than a workaround. Compounded tirzepatide from unverified sources carries serious risks, the MHRA has warned publicly about counterfeit and illegally traded weight-loss medicines, including a UK manufacturing site producing fake pens that was raided in 2025. Licensed Mounjaro supplied through a GPhC-registered pharmacy comes in the KwikPen format only, with no vial involved and no syringe needed, and our page covering what syringe to use for Mounjaro explains in more detail why the pen design makes a separate syringe unnecessary. Alongside this, many people also ask about supporting their treatment with nutrition, and our guide to the best collagen supplements to take alongside Mounjaro explains what the evidence suggests. For context on how Mounjaro compares with other available medicines, the weight-loss treatment overview is a good starting point. If you have not yet started treatment and are exploring whether Mounjaro might be appropriate for you, you can start a free consultation with our GPhC-registered prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.